NAOV NanoVibronix Inc. Market Cap to Net Assets Ratio

Official company branding of nanovibronix.com (NAOV)

NanoVibronix, Inc. generates revenue through the implementation of surface acoustic wave-based systems for wound healing and the treatment of urological infections. The price-to-book ratio history on GURU.Markets shows that the value 0.10 describes the current level of investor confidence. The business relies on a fabless model with Asian assembly, while optimized internal warehouses guarantee stable supplies to clinics.

NAOV NanoVibronix Inc.: Market Value to Book Value in the range 07/04/2022 - 12/12/2025
Original product of NanoVibronix Inc.

To objectively assess the operational success of NanoVibronix, Inc. (NAOV), investors must compare the company's market value with its net assets. This chart of the market-to-book capitalization ratio measures the premium or discount of the share price relative to the actual value of capital. The indicator's stable corridor confirms the issuer's long-term fundamental stability. For NanoVibronix, Inc. (NAOV), this balance reflects the value of its infrastructure, including the complex logistics of medical equipment delivery. Effective supply chain management directly impacts the value of the underlying assets.

Competitor analysis

DexCom, Inc. (DXCM) - Market Cap to Net Assets Ratio|Market Value to Book Value Ratio penumbrainc.com|Novanta (NOVT) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Haemonetics Corp|Inspire Sleep (INSP) - Market Capitalization to Book Value Ratio|Market Value to Book Value Procept (PRCT)|CNMD: Market Capitalization to Book Value Ratio|pulsebiosciences.com - Market-to-Book Ratio|Market Value to Book Value Ratio InMode (INMD)|PMI - Market Value to Book Value|SRDX: Market Capitalization to Book Value Ratio|SENS (Senseonics Holdings, Inc.) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio NeuroPace, Inc. NPCE|Market Capitalization to Net Assets Tactile Systems Technology Inc.|SANUWAVE - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Outset Medical Inc OM|Market Cap to Net Assets Ratio ELMD (Electromed)|LNSR - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio AVITA Medical, Inc. RCEL|PROF - Market Cap to Book Value Multiple|bairdmed.com - Market Capitalization to Book Value Ratio|EDAP TMS (EDAP) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio APYX|Market Cap to Net Assets Ratio IceCure Medical, Ltd. (ICCM)|Pulmonx Corporation (LUNG) - Market Cap to Net Assets Ratio|Market Value to Book Value TELA (telabio.com)|CytoSorbents Corporation - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Sensus Healthcare Inc SRTS|ZYXI (Zynex Inc) - Market Capitalization to Book Value Ratio|ECOR - Market-to-Book Ratio|Market Capitalization to Book Value Ratio vicarioussurgical.com|Inspira Technologies (IINN) - Capitalization to Book Value Ratio|ICU: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value IRIDEX Corp.|Market Capitalization to Book Value Ratio INBS (Intelligent Bio Solutions)|Market Cap to Net Assets Ratio beyondair.net (XAIR)|Market Capitalization to Book Value Ratio PFSA (Profusa Inc)|STRATA Skin Sciences Inc. - Market Capitalization to Book Value Ratio|GCTK - Market Value to Book Value Ratio|Venus Concept Inc (VERO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio CHF Solutions NUWE|Aethlon Medical Corp (AEMD) - Market Value to Book Value|Market Capitalization to Book Value Ratio ASXC (Asensus Surgical Inc)|Market-to-Book Ratio AVGR|BSGM: Market Value to Book Value Ratio|Market Value to Equity Ratio Cutera Inc. CUTR|Market Cap to Net Assets Ratio KNW (Know Labs Corp)|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Market Capitalization to Book Value Ratio NVRO (Nevro Corp.)|RSLS: Market Capitalization to Book Value|Market Value to Book Value Ratio Silk Road Medical (SILK)